KRASG12C inhibition enhances immunogenicity in KRASG12C-mutant colorectal cancer

被引:0
|
作者
Patel, Parasvi S.
Tian, Jun
de la Cruz, Ferran Fece
Curtis, Jacquelyn
Panda, Apekshya
Oka, Tomonori
Demehri, Shadmehr
Sade-Feldman, Moshe
Koptez, Scott
Corcoran, Ryan B.
机构
关键词
D O I
10.1158/1538-7445.AM2024-LB366
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LB366
引用
收藏
页数:2
相关论文
共 50 条
  • [1] KRAS inhibition enhances immunogenicity of KRASG12C colorectal cancer
    Tian, Jun
    de la Cruz, Ferran Fece
    Burke, Kelly
    Oka, Tomonori
    Curtis, Jacquelyn M.
    Sindurakar, Princy
    Wong, Edmond
    Demehri, Shadmehr
    Sharpe, Arlene
    Corcoran, Ryan
    CANCER RESEARCH, 2023, 83 (08)
  • [2] Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C Inhibition in KRASG12C-mutant Colorectal Cancer
    Khawaja, Hajrah
    Briggs, Rebecca
    Latimer, Cheryl H.
    Rassel, Mustasin
    Griffin, Dary
    Hanson, Lyndsey
    Bardelli, Alberto
    Di Nicolantonio, Frederica
    McDade, Simon S.
    Scott, Christopher J.
    Lambe, Shauna
    Maurya, Manisha
    Lindner, Andreas U.
    Prehn, Jochen H. M.
    Sousa, Jose
    Winnington, Chris
    LaBonte, Melissa J.
    Ross, Sarah
    Van Schaeybroeck, Sandra
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (01) : 135 - 149
  • [3] KRASG12C inhibition in colorectal cancer Comment
    Pfeiffer, Per
    Qvortrup, Camilla
    LANCET ONCOLOGY, 2022, 23 (01) : 10 - 11
  • [4] Precision oncology for KRASG12C-mutant colorectal cancer
    Di Nicolantonio, Federica
    Bardelli, Alberto
    NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (06) : 355 - 356
  • [5] Precision oncology for KRASG12C-mutant colorectal cancer
    Federica Di Nicolantonio
    Alberto Bardelli
    Nature Reviews Clinical Oncology, 2023, 20 : 355 - 356
  • [6] Bcl-xL and association with apoptosis following KRASG12C inhibition in KRASG12C mutant colorectal cancer.
    Khawaja, Hajrah
    Briggs, Rebecca
    Latimer, Cheryl
    Rassel, Md A. M. B.
    Griffin, Daryl
    Hanson, Lyndsey
    Bardelli, Alberto
    Di Nicolantonio, Federica
    McDade, Simon
    Scott, Christopher
    Lambe, Shauna
    Maurya, Manisha
    Lindner, Andreas Ulrich
    Prehn, Jochen H. M.
    Sousa, Jose
    Winnington, Chris
    LaBonte, Melissa J.
    Ross, Sarah
    Van Schaeybroeck, Sandra
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Pan-ErbB inhibition enhances activity of KRASG12C inhibitors in preclinical models of KRASG12C mutant cancers
    Robichaux, Jacqulyne P.
    Galan-Cobo, Ana
    Powell, Ried T.
    Gale, Kelly A.
    He, Jun
    Zhang, Fahao
    Nilsson, Monique B.
    Zhang, Xiang
    Sobieski, Mary M.
    Nguyen, Nghi
    Clifford, Stephan C.
    Heymach, John V.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [8] Comprehensive Clinical and Molecular Characterization of KRASG12C-Mutant Colorectal Cancer
    Henry, Jason T.
    Coker, Oluwadara
    Chowdhury, Saikat
    Shen, John Paul
    Morris, Van K.
    Dasari, Arvind
    Raghav, Kanwal
    Nusrat, Maliha
    Kee, Bryan
    Parseghian, Christine
    Pant, Shubham
    Jeyakumar, Nikeshan
    Zhu, Limin
    Nishioka, Yujiro
    Fogelman, David
    Wolff, Robert A.
    Hong, David
    Overman, Michael J.
    Vauthey, JeanNicolas
    Kopetz, Scott
    Johnson, Benny
    JCO PRECISION ONCOLOGY, 2021, 5 : 613 - 621
  • [9] TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC
    Tammaccaro, Salvina Laura
    Prigent, Philippe
    Le Bail, Jean-Christophe
    Dos-Santos, Odette
    Dassencourt, Laurent
    Eskandar, Myriam
    Buzy, Armelle
    Venier, Olivier
    Guillemot, Jean-Claude
    Veeranagouda, Yaligara
    Didier, Michel
    Spanakis, Emmanuel
    Kanno, Tokuwa
    Cesaroni, Matteo
    Mathieu, Stephane
    Canard, Luc
    Casse, Alhassan
    Windenberger, Fanny
    Calvet, Loreley
    Noblet, Laurence
    Sidhu, Sukhvinder
    Debussche, Laurent
    Moll, Jurgen
    Valtingojer, Iris
    PHARMACEUTICALS, 2023, 16 (04)
  • [10] Assessment of KRASG12C inhibitors for colorectal cancer
    Piazza, Gary A.
    Chandrasekaran, Preethi
    Maxuitenko, Yulia Y.
    Budhwani, Karim I.
    FRONTIERS IN ONCOLOGY, 2024, 14